Answers are grounded in this paper and cite their sources.
Open-label study finds 25.7% of older adults discontinue levothyroxine, suggesting evaluation of treatment necessity.
In this open-label, single-group prospective study, 25.7% of adults aged 60 years or older discontinued levothyroxine treatment while maintaining adequate thyroid function at 1 year. Evaluation of the need to continue levothyroxine should be considered in adults aged 60 years or older, particularly in those taking a dose of 50 µg/d or lower.
No takes yet. Share an insight, caveat, or question.
Ravensberg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: